Serum CA 19-9 Levels Ineffective In Distinguishing Between AIP, PDAC, Researchers Say

Gastroenterology Advisor (9/12, Khaja) reports, “Serum CA 19-9 levels are ineffective in distinguishing between autoimmune pancreatitis (AIP) and pancreatic ductal adenocarcinoma (PDAC), posing challenges in differentiating these conditions even with advanced diagnostic techniques, which may lead to unnecessary pancreatic resection, according to” researchers who “assessed 368 studies.” The results were published in BMC Gastroenterology.